United Therapeutics Stock
Price
Target price
€464.10
€464.10
0.020%
0.1
0.020%
€531.61
22:25 / Tradegate
WKN: 923818 / Symbol: UTHR / Name: Utd Therapeut / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
United Therapeutics Stock
There is nearly no change for the United Therapeutics stock today. Compared to yesterday it only changed by €0.10.
With 28 Buy predictions and 1 Sell predictions United Therapeutics is one of the favorites of our community.
With a target price of 531 € there is a slightly positive potential of 14.41% for United Therapeutics compared to the current price of 464.1 €.
So far the community has only identified positive things for United Therapeutics stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of United Therapeutics in the next few years
Pros
?
B****
?
S********** s********
?
M***** P*******
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of United Therapeutics vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| United Therapeutics | 0.020% | -0.705% | -2.802% | 79.183% | 8.776% | 110.032% | 196.051% |
| Ligand Pharmaceuticals | -0.760% | 0.000% | 2.308% | 129.310% | 60.241% | 336.066% | 155.646% |
| Ionis Pharmaceuticals Inc. | -1.470% | 4.563% | -27.823% | 38.254% | -26.825% | 40.124% | 53.915% |
| Novocure Ltd | -3.410% | 11.087% | 17.385% | 51.512% | 37.009% | -55.956% | -90.336% |
Comments
United Therapeutics (UTHR) had its price target raised by JPMorgan Chase & Co. from $685.00 to $687.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for UTHR provided by MarketBeat
United Therapeutics (UTHR) had its price target raised by Royal Bank Of Canada from $701.00 to $704.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for UTHR provided by MarketBeat
United Therapeutics (UTHR) had its "buy" rating reaffirmed by TD Cowen.
Show more
Ratings data for UTHR provided by MarketBeat